Promyelocytic Leukemia protein (PML): An ambivalent cancer regulator
April 11, 2022 2024-09-04 16:35Promyelocytic Leukemia protein (PML): An ambivalent cancer regulator
Seminar Title: ” Promyelocytic Leukemia protein (PML): An ambivalent cancer regulator”
Please go to: http://news.uoc.gr/news/2022/08-04/PapamathaiakisAnnouncement_Research_Seminar.pdf
Joint Seminar Series in Translational and Clinical Medicine: UoC Medical School – IMBB-FORTH – UCRC Wednesday, April 13, 15:00 – 16:00 local time
“Promyelocytic Leukemia protein (PML): An ambivalent cancer regulator”
Sifis Papamathaiakis, Emeritus Professor, Department of Biology, UoC & Affiliated Researcher of IMBB-FORTH
Platform link https://zoom.us/j/95222166701